BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, December 5, 2025
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 10, 2021
View Archived Issues
NeuBase reports on three programs with PATrOL-enabled genetic medicines
Read More
New GLP-1 receptor agonists identified at ILDONG Pharmaceutical
Read More
Yuhan Corp. describes compositions including GDF15 variants
Read More
Bayer patents prostaglandin E2 receptor EP3 subtype antagonists
Read More
New tucaresol prodrugs discovered at Beyondspring Pharmaceuticals
Read More
Gilead discovers Mcl-1 inhibitors
Read More
Peptide-drug conjugate PEN-221 demonstrates efficacy in patients with GI neuroendocrine tumors
Read More
Lilly's SERD LY-3484356 well tolerated in first-in-human study
Read More
Urinary CCL5 mRNA is predictive of diabetic nephropathy progression
Read More
Shoreline and BeiGene collaborate to develop and commercialize NK-based cell therapies
Read More
ReNeuron provides update for hRPC therapy candidate study
Read More
ONK Therapeutics and Trinity College Dublin collaborate in an Enterprise Ireland funded project
Read More
First patient dosed in phase I study of BTX-A51 in advanced solid tumors
Read More
Two-year follow-up data from phase I/IIa study of LiPax in non-muscle invasive bladder cancer
Read More
TAS-3681 shows safety and antitumor activity against heavily pretreated, multidrug-resistant mCRPC
Read More
Atossa presents final data from phase II endoxifen breast cancer study
Read More
First European CTA accepted for phase I/II study of INZ-701 in ABCC6 deficiency
Read More
InCarda announces progress in development program for InRhythm
Read More
Preliminary phase I results reported for OMS-906
Read More
Phase I trial evaluates M-4076 in advanced solid tumors
Read More
GigaGen initiates first-in-human study of GIGA-2050 in COVID-19
Read More
Urinary DKK3 is a biomarker of CKD progression and mortality
Read More
At ASCO, radiopharmaceuticals score with lutetium-PSMA
Read More
Oxurion receives IRB approval for phase II study of THR-687 in DME
Read More
IMDC recommends continuation of phase IIb study of nangibotide in septic shock
Read More